Heterogeneity in Microsatellite Instability in Metastatic Colorectal Cancer: Mechanisms and Clinical Implications

Author: Rona Yaeger MD
View More View Less
Restricted access
  • 1.

    Corcoran RB, Andre T, Atreya CE, . Combined BRAF, EGFR, and MEK inhibition in patients with BRAF(V600E)-mutant colorectal cancer. Cancer Discov 2018;8:428443.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Siravegna G, Lazzari L, Crisafulli G, . Radiologic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer. Cancer Cell 2018;34:148162.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Brannon AR, Vakiani E, Sylvester BE, . Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol 2014;15:454.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Hu Z, Ding J, Ma Z, . Quantitative evidence for early metastatic seeding in colorectal cancer. Nat Genet 2019;51:11131122.

  • 5.

    Yaeger R, Chatila WK, Lipsyc MD, . Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell 2018;33:125136.

  • 6.

    Ryser MD, Min BH, Siegmund KD, . Spatial mutation patterns as markers of early colorectal tumor cell mobility. Proc Natl Acad Sci U S A 2018;115:57745779.

  • 7.

    He WZ, Hu WM, Wang F, . Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer. J Natl Compr Canc Netw 2019;17:11741183.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Le DT, Durham JN, Smith KN, . Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 2017;357:409413.

  • 9.

    Overman MJ, McDermott R, Leach JL, . Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 2017;18:11821191.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Overman MJ, Lonardi S, Wong KYM, . Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 2018;36:773779.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1753 807 20
PDF Downloads 492 300 7
EPUB Downloads 0 0 0